The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation

Obesity has reached epidemic proportions. Despite a better understanding of the underlying pathophysiology and growing treatment options, a significant proportion of obese patients do not respond to treatment. Recently, microbes residing in the human gastrointestinal tract have been found to act as...

Full description

Bibliographic Details
Main Authors: Thilini N Jayasinghe, Valentina eChiavaroli, David J Holland, Wayne S Cutfield, Justin M O'Sullivan
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
FMT
GIT
Online Access:http://journal.frontiersin.org/Journal/10.3389/fcimb.2016.00015/full
id doaj-94bd2ad81b894ec89e226d5732c3a4fa
record_format Article
spelling doaj-94bd2ad81b894ec89e226d5732c3a4fa2020-11-24T22:11:21ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882016-02-01610.3389/fcimb.2016.00015173546The new era of treatment for obesity: evidence and expectations for gut microbiome transplantationThilini N Jayasinghe0Valentina eChiavaroli1David J Holland2Wayne S Cutfield3Wayne S Cutfield4Justin M O'Sullivan5Justin M O'Sullivan6The University of AucklandThe University of AucklandCounties Manukau HealthThe University of AucklandGravida: National centre for growth and developmentThe University of AucklandGravida: National centre for growth and developmentObesity has reached epidemic proportions. Despite a better understanding of the underlying pathophysiology and growing treatment options, a significant proportion of obese patients do not respond to treatment. Recently, microbes residing in the human gastrointestinal tract have been found to act as an endocrine organ, whose composition and functionality may contribute to the development of obesity. Therefore, faecal/gut microbiome transplantation (GMT), which involves the transfer of faeces from a healthy donor to a recipient, is increasingly drawing attention as a potential treatment for obesity. Currently the evidence for GMT effectiveness in the treatment of obesity is preliminary. Here, we summarize benefits, procedures, and issues associated with GMT, with a special focus on obesity.http://journal.frontiersin.org/Journal/10.3389/fcimb.2016.00015/fullObesitymicrobiotamicrobiomeFMTfecal transplantationGIT
collection DOAJ
language English
format Article
sources DOAJ
author Thilini N Jayasinghe
Valentina eChiavaroli
David J Holland
Wayne S Cutfield
Wayne S Cutfield
Justin M O'Sullivan
Justin M O'Sullivan
spellingShingle Thilini N Jayasinghe
Valentina eChiavaroli
David J Holland
Wayne S Cutfield
Wayne S Cutfield
Justin M O'Sullivan
Justin M O'Sullivan
The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
Frontiers in Cellular and Infection Microbiology
Obesity
microbiota
microbiome
FMT
fecal transplantation
GIT
author_facet Thilini N Jayasinghe
Valentina eChiavaroli
David J Holland
Wayne S Cutfield
Wayne S Cutfield
Justin M O'Sullivan
Justin M O'Sullivan
author_sort Thilini N Jayasinghe
title The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
title_short The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
title_full The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
title_fullStr The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
title_full_unstemmed The new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
title_sort new era of treatment for obesity: evidence and expectations for gut microbiome transplantation
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2016-02-01
description Obesity has reached epidemic proportions. Despite a better understanding of the underlying pathophysiology and growing treatment options, a significant proportion of obese patients do not respond to treatment. Recently, microbes residing in the human gastrointestinal tract have been found to act as an endocrine organ, whose composition and functionality may contribute to the development of obesity. Therefore, faecal/gut microbiome transplantation (GMT), which involves the transfer of faeces from a healthy donor to a recipient, is increasingly drawing attention as a potential treatment for obesity. Currently the evidence for GMT effectiveness in the treatment of obesity is preliminary. Here, we summarize benefits, procedures, and issues associated with GMT, with a special focus on obesity.
topic Obesity
microbiota
microbiome
FMT
fecal transplantation
GIT
url http://journal.frontiersin.org/Journal/10.3389/fcimb.2016.00015/full
work_keys_str_mv AT thilininjayasinghe theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT valentinaechiavaroli theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT davidjholland theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT waynescutfield theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT waynescutfield theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT justinmosullivan theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT justinmosullivan theneweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT thilininjayasinghe neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT valentinaechiavaroli neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT davidjholland neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT waynescutfield neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT waynescutfield neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT justinmosullivan neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
AT justinmosullivan neweraoftreatmentforobesityevidenceandexpectationsforgutmicrobiometransplantation
_version_ 1725806006151151616